Advertisement

Topics

Yu Shares Insight on Recent Advances in Castration-Sensitive Prostate Cancer

10:00 EDT 10 Jul 2018 | OncLive

Evan Ya-Wen Yu, MD, discusses the evolution of treatment for patients with castration-sensitive prostate cancer and how he decides between treatment with abiraterone and docetaxel for this population.

Original Article: Yu Shares Insight on Recent Advances in Castration-Sensitive Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Yu Shares Insight on Recent Advances in Castration-Sensitive Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement